Dementia and Movement Disorder Treatment Market Report

China Dementia and Movement Disorder Treatment Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 24, 2022
  • PAGES：140
  • REPORT CODE：GMM1150405
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Dementia and Movement Disorder Treatment market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Dementia and Movement Disorder Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Dementia and Movement Disorder Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Eisai

    • Eli Lilly

    • Amgen

    • Allergan

    • H Lundbeck

    • UCB

    • Novartis

    • Pfizer

    • F Hoffmann-La Roche

    • Teva Pharmaceutical Industries

    By Type:

    • MAO inhibitors (monoamine oxidase)

    • AChE inhibitors (acetylcholinesterase)

    • Glutamate inhibitors

    By End-User:

    • Branded drugs

    • Generic drugs

    • Off-label drugs

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dementia and Movement Disorder Treatment Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of MAO inhibitors (monoamine oxidase) from 2016 to 2027

    • 1.3.2 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of AChE inhibitors (acetylcholinesterase) from 2016 to 2027

    • 1.3.3 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Glutamate inhibitors from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Branded drugs from 2016 to 2027

    • 1.4.2 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Generic drugs from 2016 to 2027

    • 1.4.3 China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Off-label drugs from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Dementia and Movement Disorder Treatment Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Dementia and Movement Disorder Treatment by Major Types

    • 3.4.1 Market Size and Growth Rate of MAO inhibitors (monoamine oxidase)

    • 3.4.2 Market Size and Growth Rate of AChE inhibitors (acetylcholinesterase)

    • 3.4.3 Market Size and Growth Rate of Glutamate inhibitors

    4 Segmentation of Dementia and Movement Disorder Treatment Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Dementia and Movement Disorder Treatment by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Dementia and Movement Disorder Treatment in Branded drugs

    • 4.4.2 Market Size and Growth Rate of Dementia and Movement Disorder Treatment in Generic drugs

    • 4.4.3 Market Size and Growth Rate of Dementia and Movement Disorder Treatment in Off-label drugs

    5 Market Analysis by Regions

    • 5.1 China Dementia and Movement Disorder Treatment Production Analysis by Regions

    • 5.2 China Dementia and Movement Disorder Treatment Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Dementia and Movement Disorder Treatment Landscape Analysis

    • 6.1 North China Dementia and Movement Disorder Treatment Landscape Analysis by Major Types

    • 6.2 North China Dementia and Movement Disorder Treatment Landscape Analysis by Major End-Users

    7 Central China Dementia and Movement Disorder Treatment Landscape Analysis

    • 7.1 Central China Dementia and Movement Disorder Treatment Landscape Analysis by Major Types

    • 7.2 Central China Dementia and Movement Disorder Treatment Landscape Analysis by Major End-Users

    8 South China Dementia and Movement Disorder Treatment Landscape Analysis

    • 8.1 South China Dementia and Movement Disorder Treatment Landscape Analysis by Major Types

    • 8.2 South China Dementia and Movement Disorder Treatment Landscape Analysis by Major End-Users

    9 East China Dementia and Movement Disorder Treatment Landscape Analysis

    • 9.1 East China Dementia and Movement Disorder Treatment Landscape Analysis by Major Types

    • 9.2 East China Dementia and Movement Disorder Treatment Landscape Analysis by Major End-Users

    10 Northeast China Dementia and Movement Disorder Treatment Landscape Analysis

    • 10.1 Northeast China Dementia and Movement Disorder Treatment Landscape Analysis by Major Types

    • 10.2 Northeast China Dementia and Movement Disorder Treatment Landscape Analysis by Major End-Users

    11 Southwest China Dementia and Movement Disorder Treatment Landscape Analysis

    • 11.1 Southwest China Dementia and Movement Disorder Treatment Landscape Analysis by Major Types

    • 11.2 Southwest China Dementia and Movement Disorder Treatment Landscape Analysis by Major End-Users

    12 Northwest China Dementia and Movement Disorder Treatment Landscape Analysis

    • 12.1 Northwest China Dementia and Movement Disorder Treatment Landscape Analysis by Major Types

    • 12.2 Northwest China Dementia and Movement Disorder Treatment Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Eisai

      • 13.1.1 Eisai Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Eli Lilly

      • 13.2.1 Eli Lilly Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Amgen

      • 13.3.1 Amgen Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Allergan

      • 13.4.1 Allergan Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 H Lundbeck

      • 13.5.1 H Lundbeck Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 UCB

      • 13.6.1 UCB Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Novartis

      • 13.7.1 Novartis Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Pfizer

      • 13.8.1 Pfizer Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 F Hoffmann-La Roche

      • 13.9.1 F Hoffmann-La Roche Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Teva Pharmaceutical Industries

      • 13.10.1 Teva Pharmaceutical Industries Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of MAO inhibitors (monoamine oxidase) from 2016 to 2027

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of AChE inhibitors (acetylcholinesterase) from 2016 to 2027

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Glutamate inhibitors from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Branded drugs from 2016 to 2027

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Generic drugs from 2016 to 2027

    • Figure China Dementia and Movement Disorder Treatment Market Size and Growth Rate of Off-label drugs from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Dementia and Movement Disorder Treatment Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Dementia and Movement Disorder Treatment Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Dementia and Movement Disorder Treatment

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Dementia and Movement Disorder Treatment by Different Types from 2016 to 2027

    • Table Consumption Share of Dementia and Movement Disorder Treatment by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of MAO inhibitors (monoamine oxidase)

    • Figure Market Size and Growth Rate of AChE inhibitors (acetylcholinesterase)

    • Figure Market Size and Growth Rate of Glutamate inhibitors

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Dementia and Movement Disorder Treatment by Different End-Users from 2016 to 2027

    • Table Consumption Share of Dementia and Movement Disorder Treatment by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Branded drugs

    • Figure Market Size and Growth Rate of Generic drugs

    • Figure Market Size and Growth Rate of Off-label drugs

    • Table China Dementia and Movement Disorder Treatment Production by Regions

    • Table China Dementia and Movement Disorder Treatment Production Share by Regions

    • Figure China Dementia and Movement Disorder Treatment Production Share by Regions in 2016

    • Figure China Dementia and Movement Disorder Treatment Production Share by Regions in 2021

    • Figure China Dementia and Movement Disorder Treatment Production Share by Regions in 2027

    • Table China Dementia and Movement Disorder Treatment Consumption by Regions

    • Table China Dementia and Movement Disorder Treatment Consumption Share by Regions

    • Figure China Dementia and Movement Disorder Treatment Consumption Share by Regions in 2016

    • Figure China Dementia and Movement Disorder Treatment Consumption Share by Regions in 2021

    • Figure China Dementia and Movement Disorder Treatment Consumption Share by Regions in 2027

    • Table North China Dementia and Movement Disorder Treatment Consumption by Types from 2016 to 2027

    • Table North China Dementia and Movement Disorder Treatment Consumption Share by Types from 2016 to 2027

    • Figure North China Dementia and Movement Disorder Treatment Consumption Share by Types in 2016

    • Figure North China Dementia and Movement Disorder Treatment Consumption Share by Types in 2021

    • Figure North China Dementia and Movement Disorder Treatment Consumption Share by Types in 2027

    • Table North China Dementia and Movement Disorder Treatment Consumption by End-Users from 2016 to 2027

    • Table North China Dementia and Movement Disorder Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure North China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2016

    • Figure North China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2021

    • Figure North China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2027

    • Table Central China Dementia and Movement Disorder Treatment Consumption by Types from 2016 to 2027

    • Table Central China Dementia and Movement Disorder Treatment Consumption Share by Types from 2016 to 2027

    • Figure Central China Dementia and Movement Disorder Treatment Consumption Share by Types in 2016

    • Figure Central China Dementia and Movement Disorder Treatment Consumption Share by Types in 2021

    • Figure Central China Dementia and Movement Disorder Treatment Consumption Share by Types in 2027

    • Table Central China Dementia and Movement Disorder Treatment Consumption by End-Users from 2016 to 2027

    • Table Central China Dementia and Movement Disorder Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2016

    • Figure Central China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2021

    • Figure Central China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2027

    • Table South China Dementia and Movement Disorder Treatment Consumption by Types from 2016 to 2027

    • Table South China Dementia and Movement Disorder Treatment Consumption Share by Types from 2016 to 2027

    • Figure South China Dementia and Movement Disorder Treatment Consumption Share by Types in 2016

    • Figure South China Dementia and Movement Disorder Treatment Consumption Share by Types in 2021

    • Figure South China Dementia and Movement Disorder Treatment Consumption Share by Types in 2027

    • Table South China Dementia and Movement Disorder Treatment Consumption by End-Users from 2016 to 2027

    • Table South China Dementia and Movement Disorder Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure South China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2016

    • Figure South China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2021

    • Figure South China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2027

    • Table East China Dementia and Movement Disorder Treatment Consumption by Types from 2016 to 2027

    • Table East China Dementia and Movement Disorder Treatment Consumption Share by Types from 2016 to 2027

    • Figure East China Dementia and Movement Disorder Treatment Consumption Share by Types in 2016

    • Figure East China Dementia and Movement Disorder Treatment Consumption Share by Types in 2021

    • Figure East China Dementia and Movement Disorder Treatment Consumption Share by Types in 2027

    • Table East China Dementia and Movement Disorder Treatment Consumption by End-Users from 2016 to 2027

    • Table East China Dementia and Movement Disorder Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure East China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2016

    • Figure East China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2021

    • Figure East China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2027

    • Table Northeast China Dementia and Movement Disorder Treatment Consumption by Types from 2016 to 2027

    • Table Northeast China Dementia and Movement Disorder Treatment Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Dementia and Movement Disorder Treatment Consumption Share by Types in 2016

    • Figure Northeast China Dementia and Movement Disorder Treatment Consumption Share by Types in 2021

    • Figure Northeast China Dementia and Movement Disorder Treatment Consumption Share by Types in 2027

    • Table Northeast China Dementia and Movement Disorder Treatment Consumption by End-Users from 2016 to 2027

    • Table Northeast China Dementia and Movement Disorder Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2016

    • Figure Northeast China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2021

    • Figure Northeast China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2027

    • Table Southwest China Dementia and Movement Disorder Treatment Consumption by Types from 2016 to 2027

    • Table Southwest China Dementia and Movement Disorder Treatment Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Dementia and Movement Disorder Treatment Consumption Share by Types in 2016

    • Figure Southwest China Dementia and Movement Disorder Treatment Consumption Share by Types in 2021

    • Figure Southwest China Dementia and Movement Disorder Treatment Consumption Share by Types in 2027

    • Table Southwest China Dementia and Movement Disorder Treatment Consumption by End-Users from 2016 to 2027

    • Table Southwest China Dementia and Movement Disorder Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2016

    • Figure Southwest China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2021

    • Figure Southwest China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2027

    • Table Northwest China Dementia and Movement Disorder Treatment Consumption by Types from 2016 to 2027

    • Table Northwest China Dementia and Movement Disorder Treatment Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Dementia and Movement Disorder Treatment Consumption Share by Types in 2016

    • Figure Northwest China Dementia and Movement Disorder Treatment Consumption Share by Types in 2021

    • Figure Northwest China Dementia and Movement Disorder Treatment Consumption Share by Types in 2027

    • Table Northwest China Dementia and Movement Disorder Treatment Consumption by End-Users from 2016 to 2027

    • Table Northwest China Dementia and Movement Disorder Treatment Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2016

    • Figure Northwest China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2021

    • Figure Northwest China Dementia and Movement Disorder Treatment Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of H Lundbeck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of H Lundbeck

    • Figure Sales and Growth Rate Analysis of H Lundbeck

    • Figure Revenue and Market Share Analysis of H Lundbeck

    • Table Product and Service Introduction of H Lundbeck

    • Table Company Profile and Development Status of UCB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB

    • Figure Sales and Growth Rate Analysis of UCB

    • Figure Revenue and Market Share Analysis of UCB

    • Table Product and Service Introduction of UCB

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of F Hoffmann-La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche

    • Table Product and Service Introduction of F Hoffmann-La Roche

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US